Annals of Vascular Medicine and Research

Increased QRS Complex Voltage or ECG Signs of Left Ventricular Hypertrophy in Acute Myocardial Ischemia

Review Article | Open Access

  • 1. International Laser Center CVTI, Ilkovicova 3, 84104 Bratislava, Slovak Republic
+ Show More - Show Less
Corresponding Authors
Ljuba Bacharova, International Laser Center CVTI, Ilkovicova 3, 84104, Bratislava, Slovak Republic, Fax: 4212 654 23 244; Tel: 421 905 401 634

ECG criteria for left ventricular hypertrophy and ECG criteria for acute ischemia/ myocardial infarction represent two distinct categories. ECG signs of left ventricular hypertrophy (ECG-LVH) are based on so-called voltage criteria, i.e. the increased amplitude of QRS complex. On the other hand, the standard ECG diagnosis of MI is based on the presence of pathological Q waves and ST segment deviations and additionally on the so-called STEMI equivalents. However, animal, as well as clinical studies bring evidence on the occurrence of the increased QRS voltage /ECG-LVH signs in acute ischemia. This paper is focused on the pathophysiological mechanisms that are common for both hypertrophied and ischemic myocardium and thus can lead to identical QRS patterns. Recognizing the underlying mechanisms of the ECG-LVH patterns in myocardial ischemia has a strong clinical implication. The ECG-LVH signs/ the increased QRS voltage need to be recognized as a predictive electrophysiological marker independent of LV anatomy. Its misinterpretation in patients with acute coronary syndrome can lead to reperfusion delays and worst outcomes.


Bacharova L (2022) Increased QRS Complex Voltage/ ECG Signs of Left Ventricular Hypertrophy in Acute Myocardial Ischemia. Ann Vasc Med Res 9(3): 1151.


Electrocardiography (ECG) is the basic initial noninvasive test for diagnosing acute myocardial ischemia and myocardial infarction (MI). The recognition of the ECG manifestation of acute myocardial ischemia is of an utmost clinical importance, since it usually determines the subsequent diagnostic and therapeutic interventions. The basic standard ECG diagnosis of MI is based on the presence of ST segment deviations and pathological Q waves. Regarding the QRS complex evaluation, it includes also the poor progression of R wave in leads V2-V4, absence R wave V1-V2, or tall R waves V1-V4 [1,2]. However, it is documented that a relatively high proportion of patients with acute MI / coronary syndrome that should be justified for a rapid coronary intervention are not recognized using current strict ECG criteria [3-5]. Additional “STEMI equivalents” have been therefore identified, such as Wellens’ syndrome, de Winter sign, hyperacute T waves, left bundle branch block-including paced rhythm-and right bundle branch block [6,7]. This paper is focused on another QRS pattern, which represents a different ECG diagnostic category - the increased QRS voltage consistent with ECG criteria for left ventricular hypertrophy (ECG-LVH criteria). The increased QRS voltage in acute ischemia has been documented in both animals, as well as in clinical studies [8-11]. The increased QRS complex voltage/ ECG-LVH are here discussed as a possible manifestation of acute myocardial ischemia.

ECG signs of left ventricular hypertrophy

At first, I need to express clearly my position in the ECG-LVH diagnosis. The classical diagnosis of ECG-LVH is based on the increased QRS voltage and postulates that bigger / hypertrophied left ventricle producing a stronger electric field is associated with the increased QRS voltage. However, it has been repeatedly documented that the sensitivity of ECG-LVH criteria is very low; it means in other words that the association between increased QRS voltage and the increased LV mass is poor [12]. Also, it has been shown that the increased QRS voltage is a significant independent cardiovascular risk factor, i.e. independent on the increased left ventricular mass [13,14]. It is generally assumed that ECG-LVH criteria have high specificity and really, a number of papers document their high specificity. However, the systematic review published in 2007 showed that the specificity is actually ranging from 53 to 100 %12. It means that the increased QRS voltage is also seen in other cardiac pathology. It is thus obvious that the increased QRS voltage reflects a cardiac pathology, not necessarily associated with the increased LV mass. The suggested shift in paradigm of ECH-LVH defines the altered electrical properties of myocardium as the major determinant of the increased QRS voltage [15].

Experimental acute ischemia – animal studies

Holland and Brooks [16] documented the effect of acute ischemia on the QRS complex changes in a porcine model of myocardial infarction. During the initial phase of ischemia they observed a transient decrease in the R wave voltage, followed by marked increase in R wave voltage associated with marked decrease in conduction time indicating a decrease in conduction velocity. Similar synchronous biphasic association between ventricular activation pattens and R wave changes were found also in a canine model of myocardial ischemia [17], these changes in QRS amplitude were not related to ventricular dimensions. They concluded that in acute ischemia, the major factor affecting the QRS voltage is the ventricular activation time rather than the changes in ventricular dimensions. It was also shown that this increase in the R wave amplitude is predictive of malignant ventricular arrhythmias [8]. Barnhill et al. [18], compared the QRS amplitude changes during transient myocardial ischemia in patients with variant angina pectoris and in a canine preparation. The QRS complex changes in the dog preparation were practically identical to those in the patients and strongly correlated with a decrease in myocardial conduction velocity. They attributed the QRS changes during variant angina to the altered excitation pattern due to conduction delay in the ischemic zone.

Acute ischemia: stress test

The increased QRS amplitude has been observed in patients with coronary artery disease during the stress test. Bonoris et al. 1978 [19], showed that considering the increase in R wave additionally to the ST segment depression during the stress test the sensitivity and specificity of stress testing can be significantly improved. Similarly, Christison et al. [20], considered no change or an increase in R-wave amplitude during the stress test as a more reliable indicator of coronary artery disease than ST segment changes. The increased R wave / QRS voltage was described as additional useful information in patients with coronary artery disease [21,22]. Based on the exercise-induced changes in QRS amplitude the Athens score was developed for the diagnosis and assessment of severity of coronary artery disease [22-24]. It has been suggested that these exercise-induced QRS changes reflected in the Athens QRS score are related to exerciseinduced myocardial ischemia. It has been also discussed that the R wave increase during exercise is associated with an increase in the chamber size in patients with coronary artery disease, i.e. to the “Brody effect”. However, it was found in animal, as well as in human studies that the changes in the R wave amplitude do not correlate with the LV volume changes [17,25].

On the other hand, there are also opposite views. Van Tellingen et al. [26], did not find the combined interpretation of ST segment and R wave very efficient although useful. The association between ischemic episodes and often noted R wave amplitude changes during exercise was questioned also by [27,28]. In spite of controversial findings, the increased QRS voltage is frequently observed in patients with CAD during exercise, and cannot be ignored.

Clinical setting

Transient ECG-LVH signs are also observed in patients admitted to the emergency department [9]. Giant R wave have been repeatedly described in unstable angina and acute myocardial infarction [18,29-33].

These findings were not stable during serial measurement and did not correlate with anatomical LVH, and were earmarked as confounding [11]. However, if the increased voltage is not related to the anatomical LVH, and although it appears transiently in the acute phase, another explanation is needed in patients with acute coronary syndrome. It needs to be also stressed that ECG-LVH signs in patients with symptoms suggesting acute cardiac ischemia is a serious finding regarding the short-term mortality. As well, these patients were more likely having additional cardiac conditions associated with myocardial ischemia, such as congestive heart failure and hypertensive heart disease [10,34].

Screening, general population

In this context it is necessary to mention that it has been well-known for years that ECG-LVH is associated with significant cardiac morbidity and mortality, as has been well documented repeatedly [13,14,35-40]. It is listed as the “target organ damage” in hypertension guidelines [41,42]. The importance of the ECG-LVH was stressed already in 1991 by Kannel [13]:“ECGLVH was associated with a 3-15-fold increase of cardiovascular events with greatest risk ratios for cardiac failure and stroke. No other risk factor approaches LVH in potency”. It is therefore not comprehensible why this potent CV risk factor is not included into CV risk scores, even not in the Framingham score [43-45]. Summarizing, the ECG-LVH / increased QRS voltage reflects a cardiac pathology, sometimes transient, not necessarily associated with the increased LV mass, and it is an ominous sign.

Electrophysiological characteristics of ischemic myocardium

Ischemia influences electrophysiological properties of myocardium remarkably. The alterations in conduction velocity are studied extensively especially in relation to arrhythmias, however, they naturally alter the sequence of impulse propagation in ventricles as well, and consequently the QRS complex pattern.


The extreme ischemic damage of cardiomyocytes leads to necrosis. But, also the cardiomyocytes in surviving tissue are considerable affected. The ischemic alteration includes reduction of the number of gap junctions and their distribution, as well as reduced connexin43 level and expression [46,47]. The cardiomyocytes at the border of healed infarcts differ significantly in the number of gap junctions and their distribution compared to the healthy tissue [48,49]. And even the myocardium distant from infarction in patients with ischemic heart disease has a 47% reduction in gap junction surface area per unit cell volume, and a 30% reduction per cell [46]. Following the myocardial infarction the volume fraction of fibroblasts in myocardium adjacent to the infarcted area increases, and the myocyte volume fraction decreases [49]. Fibroblasts transformed to myofibroblasts also express connexins43 and thus can facilitate heterocellular electrical coupling between myocytes and fibroblasts [50,51].


An integral part of ischemic rebuilding of myocardium is fibrosis. It could be a diffuse process, or can create localized fibrous tissue depositions, including post-infarction scars [52]. It affects considerably the electrical connection between cardiomyocytes as well as the electrical impulse propagation, these phenomena being extensively described and studied in relation to ventricular arrhythmias, as factors creating substrate for triggering and maintaining ventricular arrhythmia [53]. However, the underlaying structural and electrophysiological changes of myocardium during acute/ chronic ischemia alter significantly the impulse propagation and consequently affect the QRS complex pattern as well.


The effect of the diffuse activation slowing in left ventricle, as well as localized conduction velocity slowing was studied using a computer simulation [54,55]. It was shown that the diffuse slowing in conduction velocity in the left ventricle results in the increase in the QRS complex amplitude, consistent with the ECGLVH criteria [54] and that the slowed conduction velocity is the major determinant of the increased QRS amplitude, and not the LV size. The combination of regional slowed conduction and areas of electrically inactive areas (as in the myocardial infarction) resulted in a range of QRS (and ST segment) changes including the increased QRS amplitude [55].

Both left ventricular hypertrophy (LVH) and ischemia alter electrical properties of ventricular myocardium and slow electrical impulse propagation. This can be the common underlying pathophysiological mechanism leading to the increased QRS complex voltage. Additionally, LVH and ischemia are interrelated, and can further enhance this phenomenon.

Figure 1: Both left ventricular hypertrophy (LVH) and ischemia alter electrical properties of ventricular myocardium and slow electrical impulse propagation. This can be the common underlying pathophysiological mechanism leading to the increased QRS complex voltage. Additionally, LVH and ischemia are interrelated, and can further enhance this phenomenon.


The standard pathophysiological interpretation of ECG findings in MI

The basic classical electrophysiological mechanisms considered in interpreting the ECG findings in MI include predominantly the ST segment deviations and pathological Q waves. The interpretation of the ST segment deviations in MI refers to the “injury current”, resulting from the voltage difference between the ischemic and non-ischemic myocardium during the resting and plateau phases of the ventricular action potential [56,57]. The pathological Q waves are basically interpreted as an absence of localized electrical activity that can be due to necrosis or a fibrotic scar. However, the whole spectrum of structural and functional/ electrophysiological changes due to acute / chronic ischemia is much more complex and complicated and this is somehow neglected in interpreting the QRS patterns, although these substantially more complicated processes are well-described and studied in details in relation to ventricular arrhythmias.


To summarize, the myocardial ischemia alters the structure and electrophysiological properties of myocardium considerably, changing the organization, distribution, and electrophysiological characteristics of cardiomyocytes, as well as of interstitium. Direct measurements, as well as computer simulations document conductivity alteration at cellular and tissue levels, results in altered electrical impulse propagation in the ventricles, subsequently modifying the sequence of depolarization that is reflected in the QRS patterns (Figure 1). Since the mental/ diagnostic association between ECG-LVH signs and LVH diagnosis is strong, the occurrence of ECG-LVH signs is sometimes misinterpreted as “confounding” since it does not reflect the size of the ventricles. However, there is strong evidence that the increased QRS voltage consistent with ECG-LVH criteria can reflect the altered sequence of ventricular depolarization due to ischemia [15]. The understanding of the effect of the disturbances due to ischemia on the electrical impulse propagation in ventricles and subsequently on the resultant QRS pattern has a strong clinical implication. The ECG-LVH signs/ the increased QRS voltage need to be recognized as a predictive electrophysiological marker independent of LV anatomy. Its misinterpretation in patients with acute coronary syndrome can lead to reperfusion delays and worst outcomes.


This paper was partly supported by the grant of the Slovak Research Agency: VEGA 2/0109/22.


1. Pentti M Rautaharju, Borys Surawicz, Leonard S Gettes, James J Bailey, Rory Childers, Barbara J Deal. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, t and u waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. Circulation. 2009; 53: 982-91.

2. Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/ infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009; 53: 1003– 11.

3. Aslanger EK, Meyers PH, Smith SW. STEMI: A transitional fossil in MI classification? J Electrocardiol. 2021; 65: 163–169.

4. Aslanger EK, Meyers PH, Smith SW. Time for a new paradigm shift in myocardial infarction. Anatol J Cardiol. 2021; 25: 156–161.

5. Tziakas D, Chalikias G, Al-Lamee R, Kaski JC. Total coronary occlusion in non ST elevation myocardial infarction: Time to change our practice? Int J Cardiol. 2021; 329: 1–8.

6. Tzimas G, Antiochos P, Monney P, Eeckhout E, Meier D, Fournier S, et al. Atypical Electrocardiographic Presentations in Need of Primary Percutaneous Coronary Intervention. Am J Cardiol. 2019; 124: 1305– 14.

7. Salihu A, Roux O, Tzimas G, Antiochos P, le Bloa M, Fournier S, et al. An update on some atypical electrocardiographic forms of acute coronary syndrome The “STEMI equivalents”. Rev Med Suisse. 2022; 18: 1030– 7.

8. David D, Michelson EL, Naito M, Schaffenburg M, Dreifus LS. Increased R-wave amplitude induced by acute myocardial ischemia in the dog: a predictor of malignant ventricular arrhythmias. Am J Cardiol. 1982; 50: 844–8.

9. Shoenberger JM, Voskanian S, Johnson S, Ahern T, Henderson SO. Left ventricular hypertrophy may be transient in the emergency department. West J Emerg Med. 2009; 10: 140–3.

10. Larsen GC, Griffith JL, Beshansky JR, D’Agostino RB, Selker HP. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study. J Gen Intern Med. 1994; 9: 666–73.

11. Brady WJ, Lentz B, Barlotta K, Harrigan RA, Chan T. ECG patterns confounding the ECG diagnosis of acute coronary syndrome: left bundle branch block, right ventricular paced rhythms, and left ventricular hypertrophy. Emerg Med Clin North Am. 2005; 23: 999– 1025.

12. Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007; 335: 711–4.

13. Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens Suppl. 1991; 9: S3–9.

14. Adam Leigh J, O’Neal WT, Soliman EZ. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years. Am J Cardiol. 2016; 117: 1831–5.

15. Bacharova L. ECG in left ventricular hypertrophy: A change in paradigm from assessing left ventricular mass to its electrophysiological properties. J Electrocardiol. 2022; 73: 153-6.

16. Holland RP, Brooks H. The QRS complex during myocardial ischemia. An experimental analysis in the porcine heart. J Clin Invest. 1976; 57: 541–50.

17. David D, Naito M, Michelson E, Watanabe Y, Chen CC, Morganroth J, et al. Intramyocardial conduction: a major determinant of R-wave amplitude during acute myocardial ischemia. Circulation. 1982; 65: 161–7.

18. Barnhill JE, Wikswo JP, Dawson AK, Gundersen S, Robertson RM, Robertson D, et al. The QRS complex during transient myocardial ischemia: Studies in patients with variant angina pectoris and in a canine preparation. Circulation. 1985; 71: 901–11.

19. Bonoris PE, Greenberg PS, Christison GW, Castellanet MJ, Ellestad MH. Evaluation of R wave amplitude changes versus ST-segment depression in stress testing. Circulation. 1978; 57: 904–10.

20. Christison GW, Bonoris PE, Greenberg PS, Castellanet MJ, Ellestad MH. Predicting coronary artery disease with treadmill stress testing: changes in R-wave amplitude compared with ST segment depression. J Electrocardiol. 1979; 12: 179–85.

21. Frass M, Glogar D, Probst P, Schuster J, Kaindl F. R-wave amplitude changes during exercise stress testing: patients with dilative cardiomyopathy compared to patients with coronary artery disease. J Electrocardiol. 1987; 20: 260–71.

22. Miyakoda H, Kitamura H, Kinugawa T, Ogino K, Hoshio A, Kotake H, et al. Diagnostic value of R-wave amplitude increase during treadmill exercise testing for detecting coronary artery disease. Jpn Circ J. 1990; 54: 1503–10.

23. Michaelides AP, Triposkiadis FK, Boudoulas H, Spanos AM, Papadopoulos PD, Kourouklis KV, et al. New coronary artery disease index based on exercise-induced QRS changes. Am Heart J. 1990; 120: 292–302.

24. van Campen CMC, Visser FC, Visser CA. The QRS score: a promising new exercise score for detecting coronary artery disease based on exercise-induced changes of Q-, R- and S-waves: a relationship with myocardial ischaemia. Eur Heart J. 1996; 17: 699–708.

25. Ohlmeier H, Mannebach H, Gleichmann U. Correlation between R-wave amplitude and left ventricular volume at rest and with exercise. Clin Cardiol. 1983; 6: 29–36.

26. van Tellingen C, Ascoop CA, Rijneke RD. On the clinical value of conventional and new exercise electrocardiographic criteria: a comparative study. Int J Cardiol. 1984; 5: 689–702.

27. Wagner S, Cohn K, Selzer A. Unreliability of exercise-induced R wave changes as indexes of coronary artery disease. Am J Cardiol. 1979; 44: 1241–6.

28. Grosse-Heitmeyer W, Hagemeier M. Behavior of the R-amplitude in ergometric and pharmacologic stress in comparison with coronary morphologic findings in patients with coronary heart disease. Med Klin (Munich). 1993; 88: 117–24.

29. Chugh Y, Maraboto C, Christia P, Faillace R. Transient Giant R Wave as a Marker for Ischemia in Unstable Angina. Cureus. 2017; 9.

30. Faillace RT, Akiyama T, Chang W. The giant R wave of acute myocardial infarction. Jpn Heart J. 1985; 26: 165–78.

31. Madias JE. Spontaneous angina in the coronary care unit. II. Electrocardiographic changes during and after chest pain. Chest. 1982; 82: 279–84.

32. Madias JE. The earliest electrocardiographic sign of acute transmural myocardial infarction. J Electrocardiol. 1977; 10: 193–6.

33. Schick EC, Weiner DA, Hood WB, Ryan TJ. Increase in R-wave amplitude during transient epicardial injury (Prinzmetal type). J Electrocardiol. 1980; 13: 259–66.

34. Pope JH, Ruthazer R, Kontos MC, Beshansky JR, Griffith JL, Selker HP. The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: A multicenter study. Am J Emerg Med. 2004 ;22: 156–63.

35. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970; 72: 813–22.

36. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: The Framingham study. Am Heart J. 1986; 111: 391–7.

37. Rautaharju PM, Soliman EZ. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: A critical appraisal. J Electrocardiol. 2014; 47: 649–54.

38. Tanaka K, Tanaka F, Onoda T, Tanno K, Ohsawa M, Sakata K, et al. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population. Am J Hypertens. 2018; 31: 895–901.

39. Li Z, Yang Y, Zheng L, Sun G, Guo X, Sun Y. It’s Time to Add Electrocardiography and Echocardiography to CVD Risk Prediction Models: Results from a Prospective Cohort Study. Risk Manag Healthc Policy. 2021; 14: 4657–4671.

40. Menotti A, Puddu PE, Tolonen H, Kafatos A, Adachi H. High R wave as a risk factor for cardiovascular and all-cause mortality. A 45-year follow-up of 13 cohorts of the Seven Countries Study. J Electrocardiol. 2022; 73: 103–107.

41. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. J Hypertens. 2018; 36: 1953-2041.

42. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31: 1281–357.

43. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837–47.

44. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117: 743–53.

45. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42: 2439- 54.

46. Peters NS. New insights into myocardial arrhythmogenesis: Distribution of gap-junctional coupling in normal, ischaemic and hypertrophied human hearts. Clin Sci. 1996; 90: 447–52.

47. Greiner J, Sankarankutty AC, Seidel T, Sachse FB. Confocal microscopybased estimation of intracellular conductivities in myocardium for modeling of the normal and infarcted heart. Comput Biol Med. 2022; 146.

48. Peters NS. Myocardial gap junction organization in ischemia and infarction. Microsc Res Tech. 1995; 31: 375–86.

49. Schwab BC, Seemann G, Lasher RA, Torres NS, Wulfers EM, Arp M, et al. Quantitative analysis of cardiac tissue including fibroblasts using three-dimensional confocal microscopy and image reconstruction: Towards a basis for electrophysiological modeling. IEEE Trans Med Imaging. 2013; 32: 862–72.

50. Baum JR, Long B, Cabo C, Duffy HS. Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. Am J Physiol Heart Circ Physiol. 2012; 302.

51. McArthur L, Chilton L, Smith GL, Nicklin SA. Electrical consequences of cardiac myocyte: Fibroblast coupling. Biochem Soc Trans. 2015; 43: 513–8.

52. Verheule S, Schotten U. Electrophysiological consequences of cardiac fibrosis. Cells. 2021; 10.

53. Morita N, Mandel WJ, Kobayashi Y, Karagueuzian HS. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. J Arrhythm. 2014; 30: 389–94.

54. Bacharova L, Szathmary V, Kovalcik M, Mateasik A. Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study. J Electrocardiol. 2010; 43: 200–8.

55. Bacharova L, Szathmary V, Mateasik A. QRS complex and ST segment manifestations of ventricular ischemia: the effect of regional slowing of ventricular activation. J Electrocardiol. 2013; 46: 497–504.

56. Kleber AG, Janse MJ, van Capelle FJL, Durrer D. Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ Res. 1978; 42: 603–13.

57. Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM, et al. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram. Part VI: Acute Ischemia/ Infarction A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation. Journal of the American College of Cardiology. 2009; 53: 1003–11.

Bacharova L (2022) Increased QRS Complex Voltage/ ECG Signs of Left Ventricular Hypertrophy in Acute Myocardial Ischemia. Ann Vasc Med Res 9(3): 1151.

Received : 11 Oct 2022
Accepted : 29 Nov 2022
Published : 29 Nov 2022
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
TEST Journal of Dentistry
ISSN : 1234-5678
Launched : 2014
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X